Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

RBC Cuts Price Target on Fresenius Medical Care to $35 From $42, Citing Sector Re-Rating, Maintains Sector Perform Rating

11/17/2021 | 07:40am EST


ę MT Newswires 2021
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
01/25European ADRs Move Lower in Tuesday Trading
MT
01/25KIDNEYCARE : 365 CKD Program Earns NCQA Accreditation
PU
01/25FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan keeps a Sell rating
MD
01/19European ADRs Move Higher in Wednesday Trading
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/17FMC FRESENIUS MEDICAL CARE AG & CO K : Sell rating from JP Morgan
MD
01/14European ADRs Move Higher in Friday Trading
MT
01/13FRESENIUS MEDICAL CARE : FKC Partners with Biim Ultrasound AS
PU
01/13Thyssenkrupp's hydrogen business gets KGaA structure
RE
01/12FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan reiterates its Sell rating
MD
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Financials (USD)
Sales 2021 20 119 M - -
Net income 2021 1 200 M - -
Net Debt 2021 12 831 M - -
P/E ratio 2021 16,5x
Yield 2021 2,01%
Capitalization 19 648 M 19 722 M -
EV / Sales 2021 1,61x
EV / Sales 2022 1,50x
Nbr of Employees 123 528
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 67,06 $
Average target price 76,20 $
Spread / Average Target 13,6%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial & Transformation Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Executive VP-Clinical & Scientific Affairs